| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/15/2005 | EP1015035A4 Vaccination by topical application of genetic vectors |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0979099B1 Use of lactoferin in the treatment of allergen induced disorders |
| 06/15/2005 | EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 06/15/2005 | CN1628115A 哌啶衍生物 Piperidine derivatives |
| 06/15/2005 | CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 06/15/2005 | CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application |
| 06/15/2005 | CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones |
| 06/15/2005 | CN1626240A Antigen-specific lgE antibody production inhibitors |
| 06/15/2005 | CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 06/15/2005 | CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/15/2005 | CN1626188A Health product for enhancing immunity and soothing the nerves |
| 06/15/2005 | CN1626184A Combined Chinese traditional medicine for strengthening immunity, anti virus, dispeling the effects of alcohol and preventing influenza and catch cold |
| 06/15/2005 | CN1626173A Sugarless type oral liquid of rehmannia root including six elements |
| 06/15/2005 | CN1626090A Combination of medication for antivirus in use for eye region and preparation method |
| 06/15/2005 | CN1625964A Capsule of natural protein containing selenium and American ginseng |
| 06/15/2005 | CN1625963A Capsule of natural protein containing selenium and root of pilose asiabell |
| 06/15/2005 | CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/15/2005 | CN1206239C Cyclohexapeptides and their mixtures, process for preparing them, and their use |
| 06/15/2005 | CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206133C Infusion packet and its use |
| 06/15/2005 | CN1205998C Antigen-specific IgE antibody production inhibitors |
| 06/15/2005 | CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/15/2005 | CN1205984C Medicine composition with synergrstic action and preparation process and use thereof |
| 06/15/2005 | CN1205964C Medicament for curing colpitismycotica and trichomonal vaginitis and its preparation method |
| 06/15/2005 | CN1205955C Composition with intelligence-development, immunological regulation and fatigue resistance |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6905845 Isolated nucleic acids; allergies sensitivity |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | CA2285463C A combination therapy for hiv infections |
| 06/14/2005 | CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 06/14/2005 | CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 06/14/2005 | CA2150229C Nitric esters having a pharmacological activity and process for their preparation |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |
| 06/09/2005 | WO2005051406A1 Ceramidase inhibitor |
| 06/09/2005 | WO2005051405A1 Il-8 production promoters and use thereof |
| 06/09/2005 | WO2005051317A2 Substituted imidazo ring systems and methods |
| 06/09/2005 | WO2005025604A3 Use of hmgb and hmgb fragments to decrease specific immune response |
| 06/09/2005 | WO2005021003A3 Immunosuppressive effects of pteridine derivatives |
| 06/09/2005 | WO2005016893A3 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 06/09/2005 | WO2005003335A3 Rapamycin resistant t cells and therapeutic uses thereof |
| 06/09/2005 | WO2005000344A3 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124680 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 06/09/2005 | US20050124646 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 06/09/2005 | US20050124643 Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 06/09/2005 | US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124604 E.g. 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, -arthritic, -carcinogenic, -tumor, -diabetic agents; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124554 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
| 06/09/2005 | US20050124544 Peptide decoys for the preparation of medicaments intended for the prevention or treatment of autoimmune pathologies or disorders linked to the appearance of antibodies directed against exogenous proteins |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124055 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123899 Viricidal agent comprising mannose binding protein for use in directed destruction of viral particles associated with human immunodeficiency syndrome |
| 06/09/2005 | US20050123662 Soybean saponin-containing material and process for producing the same |
| 06/09/2005 | US20050123636 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123609 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/09/2005 | US20050123570 Tyrosine, modified or unmodified allergen, and 3-deactylated monophosphoryl lipid A; treating a patient susceptible to allergy |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123562 Novel composition |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | CA2547467A1 Piperidine compound and method for producing same |